Skip to main content

Overview

Overview

Skip to main content

SEC Filings Details

Form 8-K

01/12/2026

Current report filing

PDF Format Download (opens in new window)
Excel Format Download (opens in new window)
XBRL Format Download (opens in new window)
XBRL Format Download (opens in new window)

About Summit Therapeutics
Ivonescimab (SMT112)*
Pipeline
Contact

Investor Information
Reports & Filings
Share Price

Visit Linkedin, opens in a new window

Visit X (Formally Twitter), opens in a new window

Visit Facebook, opens in a new window

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

You are leaving SMMTTX.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

Summit Therapeutics Inc., is not responsible for the privacy notice of any third-party websites. We encourage you to read the privacy notice of every website you visit.

To stay on Summit’s website, click “Cancel” or click “Continue” to proceed.

Cancel
Continue

© Summit Therapeutics Inc.

Disclaimer
Privacy Notice
Cookie Preferences
Online Terms of Use

Trademarks, Registered or Otherwise, are the property of their respective owner(s).